Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Ferring-Léčiva, a.s., against the decision of the State Institute for Drug Control from 20. 7. 2020, under the no.: SUKLS26059/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

Notification of the Ministry of Health of the Czech Republic against the decision of the State Institute for Drug Control from 19. 5. 2021, under the no. SUKLS76072/2021, regarding the withdrawal of the appeal of the appelant Merck Europe B.V. The decision of the State Institute for Drug Control is valide since 8. 7. 2021.

More information - MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Accord Healthcare S.L.U., against the decision of the State Institute for Drug Control from 10. 5. 2021, under the no.: . SUKLS272727/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Les Laboratoires Servier 50, against the decision of the State Institute for Drug Control from 21. 8. 2019, under the no. SUKLS352037/2018:

• the decision under appeal is reversed and the issue is referred back to the Ministry of Health of the Czech Republic for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 14. 6. 2019, under the no.: SUKLS67945/2019:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Biogen Netherlands B. V., against the decision of the State Institute for Drug Control from 18. 6. 2019, under the no.: SUKLS233890/2018:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AstraZeneca AB, against the decision of the State Institute for Drug Control from 24. 6. 2019, under the no. SUKLS51736/2013:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 17. 6. 2019, under the no. SUKLS1852/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.